OR WAIT null SECS
December 18, 2014
Fujifilm Diosynth Biotechnologies announced the completion of the acquisition of Kalon Biotherapeutics, a company that specializes in advanced biologics development manufacturing.
December 17, 2014
FDA drug approvals are up in 2014 with biologics drugs representing more than 25% of FDA approvals to date.
December 15, 2014
Baxter announced that it had entered into an agreement to sell its Vero cell technology and related assets to Nanotherapeutics.
December 11, 2014
US Department of Health and Human Services announced a declaration to provide immunity to legal claims made in the US in relation to three investigational Ebola vaccines.
December 04, 2014
Amgen's bispecific T-cell engager (BiTE) antibody constructs help the body fight malignant cancer cells.
Spending rises on prescription drugs despite overall slow-down in health care outlays.
Sanofi executives are being charged in a whistleblower lawsuit for allegedly granting illicit payments to healthcare providers.
December 03, 2014
CytRx receives formal written communication from FDA on a prior decision for a partial clinical hold for CytRx's trials involving chemotherapeutic agent aldoxorubicin.
December 02, 2014
Ranbaxy and Epirus announce the launch of India's first biosimilar for Remicade.
On Oct. 7, 2014 at CPhI Worldwide in Paris, France, UBM Live announced the winners of the 11th annual CPhI Pharma Awards.